Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/06 (2006.01) A61K 31/47 (2006.01)

Patent

CA 2146260

The present invention is directed to compounds of formula (I), and the pharmaceutically acceptable acid addition salts thereof, wherein R is selectetd from the group consisting of F, -CF3, -OCH3, -O(C1)alkyl substituted with 1 to 3 fluoro atoms, -O(C2)alkyl substituted with 1 to 5 fluoro atoms, and -O(C3)alkyl substituted with 1 to 7 fluoro atoms. The compounds of formula (I) are useful in the treatment of stroke, traumatic brain injury and central nervous system degenerative diseases.

La présente invention concerne des composés de formule (I), et les sels d'addition acide pharmaceutiquement acceptables de ces derniers, où R est choisi parmi le groupe constitué de F, -CF3, -OCH3, -O-alkyle en C1 substitué par 1 à 3 atomes de fluor, -O-alkyle en C2 substitué par 1 à 5 atomes de fluor, et -O-alkyle en C3 substitué par 1 à 7 atomes de fluor. Les composés de formule (I) sont utiles dans le traitement des accidents cérébro-vasculaires, des traumatismes cérébraux et des maladies dégénératives du système nerveux central.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1903719

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.